Antigenic epitopes were incorporated into a dendroaspin scaffold: AHC (ApoB100 peptide?+?hHSP60 peptide [hHSP60153-163]?+?putative epitope derived from Chlamydophila pneumoniae [Cpn]) and AHHC (AHC?+?hHSP60303-312); and were compared with construct A (ApoB peptide), construct H (hHSP60153-163), and construct AH (ApoB100 peptide?+?hHSP60153-163). Immunization with 2 multiple-antigenic epitope constructs elicited high levels of antibodies against each epitope in Apobtm2SgyLdlrtm1Her J mice (apart from hHSP60153-163, which induced a low antibody response). Histological analyses demonstrated that the mice immunized with AHHC and AHC showed significant reductions in the size of atherosclerostic lesions compared with controls (63.8 % and 63.2 % ; P?<?0.001, respectively), and significantly greater reductions in lesions size compared with those after immunization with construct A (24.9 % ; P?<?0.01), H (26.8 % ; P?<?0.05), and AH (42.9 % ; P?<?0.001). Moreover, combination of 2 short Cpn peptides along with ApoB and hHSP60 peptides had an additive effect on reducing the lesion without Cpn infection. Reduction in plaque size correlated with cellular infiltration and cytokine/chemokine secretion in serum or by stimulated spleen cells as well as specific cellular immune responses when compared with controls.
Immunization of mice with a single construct containing multiple epitopes derived from ApoB100, hHSP60 and Cpn was more effective in reducing early atherosclerotic lesions through the induction of a specific Treg-cell response than was the construct containing either mono- or bi-epitopes. This approach offers attractive opportunities for the design of protein-based, multivalent vaccines against atherosclerosis.